Harnessing the Power of AI: Revolutionizing HEOR and Market Access
Speaker(s)
Moderator: Steven Laux, MBA, Trinity Life Sciences, East Norriton, PA, USA
Panelists: James Creeden, MD, PhD, CGC Consulting, Basel, Basel, Switzerland; Francesco De Solda, PharmD, MBA, Janssen Global Services LLC, Raritan, NJ, USA; Adrienne Lovink, MASc, Trinity Life Sciences, Waltham, MA, USA
Presentation Documents
Our goal is to explore approaches to leverage AI in HEOR and Market Access and relate real-world learnings. Our experts will relate their experiences on the application of AI by exploring tangible examples in HEOR and Market Access. They will share their experiences including challenges faced and best practices learned.
The symposium will explore the potential of AI to improve specific aspects of HEOR research, including methodologies and or areas where AI can be applied to improve efficiency while maintaining quality and rigor. Predictive and generative AI has the potential to transform the way pharma conducts HEOR and Market Access research through its ability to analyze and summarize large amounts of data, extract insights, and provide institutional memory to new team members. Specific applications developing content for dossiers and product value messaging, summarizing and synthesizing HTA decisions, developing access rationales and predicting access outcomes.
Panelists will discuss the importance of setting clear goals/objectives, cross-functional alignment and a multi-stakeholder approach to fully realize the potential of AI in HEOR and Market Access. Our goal is to cut through the noise and provide real-world examples of what has worked and what has not and what the future holds.
Code
134
Topic
Health Technology Assessment